THE CLINICAL NEED

Heart failure requires a more comprehensive approach to monitoring.

Heart failure is a complex, evolving condition. Understanding changes in cardiovascular pressures, fluid status, and cardiac mechanics can help inform more personalized approaches to monitoring and care.

64M[1]

People living with heart failure worldwide (2017 estimate).

50%[2]

Five-year mortality after diagnosis.

€45B[3] / US$30B[4]

Estimated annual economic burden: Europe and United States, respectively.

References: [1] Eur J Prev Cardiol. 2021;28:1682–1690 · [2] Circulation. 2021;143:e254–e743 · [3] Eur Heart J. 2025;46:3069–3078 · [4] Circ Heart Fail. 2013;6:606–619.

THE CLINICAL CHALLENGE

Recognizing deterioration before clinical decompensation.

Conventional monitoring often relies on symptoms, weight and blood pressure, discussed during phone calls or clinic visits. These approaches have limitations: by the time noticeable symptoms appear, deterioration may already be advanced.

01

Recurrent deterioration

Patients can experience progressive deterioration and recurrent decompensation despite ongoing treatment. Noticeable symptoms may emerge only after the condition has already worsened.

02

Incomplete physiological information

Symptoms, weight and blood pressure provide useful information, but may not capture all of the interacting changes in heart failure. A single physiological parameter provides only part of the picture.

03

Increasing clinical workload

Routine data review, patient follow-up and medication management place demands on clinical teams. Monitoring models need to account for this operational workload.

MULTIPARAMETRIC MONITORING

Beyond single-parameter monitoring.

Cardiovascular pressures, thoracic fluid status and cardiac mechanics reflect different aspects of a complex condition. Complementary physiological measurements can provide a broader picture than any one measurement alone.

FORESEE is developing an intravascular sensing platform designed to combine four physiological parameters:

Pulmonary artery pressure

Hemodynamic information reflecting changes in pulmonary artery pressure.

Intrathoracic impedance

Electrical measurements sensitive to changes in thoracic fluid status.

Cardiac mechanics

Information related to the heart's mechanical activity.

Temperature

An additional physiological measurement that complements the monitoring platform.

SCALABLE HEART FAILURE CARE

Better monitoring must work for thousands of patients, not just a few.

Hospitals need care models capable of supporting large heart failure populations without creating an unsustainable burden of routine data review. Collecting more information is only one part of the challenge; that information also needs to fit into a structured clinical workflow.

Structured monitoring, patient empowerment and clinician oversight may help shape care models that can serve larger populations. FORESEE is exploring this approach through its intended physician-directed patient self-management model.

(Technology under development. Improved workload efficiency and clinical outcomes have not been demonstrated for this intended service.)

PHYSICIAN-DIRECTED PATIENT SELF-MANAGEMENT

Empowering patients. Supporting clinical teams.

FORESEE's intended model is for patients to participate in routine home monitoring and structured self-management within a physician-defined care plan.

Patient participation

Patients would take routine measurements at home and follow the activities and instructions defined in their individual care plan.

Clinical oversight

Clinical teams retain oversight and responsibility for treatment decisions and escalation pathways. Treatment changes remain physician-directed.

(Technology under development, not an already validated clinical service.)

HOW FORESEE WORKS

From physiological measurements to physician-directed care.

The platform under development brings together an implant, an external unit, a delivery system and a digital application. Its intended workflow has four stages:

01

Intravascular microsensor

A wireless multiparametric intravascular microsensor is being developed to obtain physiological information. The platform includes a delivery system designed to deploy the microsensor in a branch of the pulmonary artery.

02

External unit

An external unit is designed to wirelessly power the microsensor and acquire data through communication with it. FORESEE's powering and communication approach is intended to avoid bulky components within the implant.

03

Home measurement routine

The intended routine is an approximately five-minute measurement at home. This is a target workflow under development, rather than a validated clinical service.

04

Physician-directed monitoring and care

An application would show patient parameters, trigger alerts and support monitoring and care. Information would be reviewed within a physician-defined plan, with clinical teams responsible for decisions and escalation.

SCIENTIFIC FOUNDATION

From university research to medical technology.

FORESEE is a spin-off of Universitat Pompeu Fabra (UPF) - Barcelona. Its work builds on research in bioelectrical phenomena and wireless powering of implantable devices.

Explore the technology behind FORESEE.

Discover Our Technology